Literature DB >> 21898101

Lansoprazole precipitated QT prolongation and torsade de pointes associated with disopyramide.

Hiroshi Asajima, Naotaka Saito, Yoshinori Ohmura, Kazue Ohmura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21898101     DOI： 10.1007/s00228-011-1119-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  16 in total

Review 1.  Drug-induced prolongation of the QT interval.

Authors:  Dan M Roden
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

Review 2.  Pharmacokinetic drug interaction profiles of proton pump inhibitors.

Authors:  Henning Blume; Frank Donath; André Warnke; Barbara S Schug
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Proton pump inhibitors: an update of their clinical use and pharmacokinetics.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-08-05       Impact factor: 2.953

4.  Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes.

Authors:  Z Guo; S Raeissi; R B White; J C Stevens
Journal:  Drug Metab Dispos       Date:  1997-03       Impact factor: 3.922

5.  Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy.

Authors:  Jonathan N Johnson; Camilla Grifoni; J Martijn Bos; Maha Saber-Ayad; Steve R Ommen; Stefano Nistri; Franco Cecchi; Iacopo Olivotto; Michael J Ackerman
Journal:  Eur Heart J       Date:  2011-02-22       Impact factor: 29.983

Review 6.  Drug-induced long QT and torsade de pointes: recent advances.

Authors:  Prince J Kannankeril; Dan M Roden
Journal:  Curr Opin Cardiol       Date:  2007-01       Impact factor: 2.161

Review 7.  Antiarrhythmic agents: drug interactions of clinical significance.

Authors:  T C Trujillo; P E Nolan
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

Review 8.  Clinical pharmacokinetics of disopyramide.

Authors:  L A Siddoway; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

9.  QT-interval abnormalities in hypertrophic cardiomyopathy.

Authors:  A Dritsas; E Sbarouni; D Gilligan; P Nihoyannopoulos; C M Oakley
Journal:  Clin Cardiol       Date:  1992-10       Impact factor: 2.882

10.  Severe hypomagnesaemia in long-term users of proton-pump inhibitors.

Authors:  T Cundy; A Dissanayake
Journal:  Clin Endocrinol (Oxf)       Date:  2008-01-23       Impact factor: 3.478
View more
  3 in total

1.  Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes.

Authors:  Pietro E Lazzerini; Iacopo Bertolozzi; Francesco Finizola; Maurizio Acampa; Mariarita Natale; Francesca Vanni; Rosella Fulceri; Alessandra Gamberucci; Marco Rossi; Beatrice Giabbani; Michele Caselli; Ilaria Lamberti; Gabriele Cevenini; Franco Laghi-Pasini; Pier L Capecchi
Journal:  Front Pharmacol       Date:  2018-04-20       Impact factor: 5.810

Review 2.  Association of hypomagnesemia with cardiovascular diseases and hypertension.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  Int J Cardiol Hypertens       Date:  2019-04-23

Review 3.  Pain medication and long QT syndrome.

Authors:  Christoph Klivinyi; Helmar Bornemann-Cimenti
Journal:  Korean J Pain       Date:  2018-01-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.